These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 20179909)
21. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors. Braida D; Paladini E; Griffini P; Lamperti M; Maggi A; Sala M Eur J Pharmacol; 1996 Apr; 302(1-3):13-20. PubMed ID: 8790986 [TBL] [Abstract][Full Text] [Related]
22. Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning. McDonald LM; Moran PM; Vythelingum GN; Joseph MH; Stephenson JD; Gray JA Psychopharmacology (Berl); 2003 Sep; 169(3-4):321-31. PubMed ID: 14530903 [TBL] [Abstract][Full Text] [Related]
23. Fluctuation of latent inhibition along the estrous cycle in the rat: modeling the cyclicity of symptoms in schizophrenic women? Arad M; Weiner I Psychoneuroendocrinology; 2008 Nov; 33(10):1401-10. PubMed ID: 18819755 [TBL] [Abstract][Full Text] [Related]
24. Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers. Dukoff R; Wilkinson CW; Lasser R; Friz J; Conway A; Bahro M; Peskind ER; Sunderland T Biol Psychiatry; 1999 Jul; 46(2):189-95. PubMed ID: 10418693 [TBL] [Abstract][Full Text] [Related]
25. The morphine sparing effect of physostigmine. Patil CS; Kulkarni SK Methods Find Exp Clin Pharmacol; 1999 Oct; 21(8):523-7. PubMed ID: 10599050 [TBL] [Abstract][Full Text] [Related]
26. Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia. Barak S; Arad M; De Levie A; Black MD; Griebel G; Weiner I Neuropsychopharmacology; 2009 Jun; 34(7):1753-63. PubMed ID: 19158670 [TBL] [Abstract][Full Text] [Related]
28. N-tert-butyl-alpha-phenylnitrone, a free radical scavenger with anticholinesterase activity does not improve the cognitive performance of scopolamine-challenged rats. Milivojevic N; Babic K; Milatovic D; Dettbarn WD; Sket D; Zivin M Int J Dev Neurosci; 2001 Jun; 19(3):319-25. PubMed ID: 11337201 [TBL] [Abstract][Full Text] [Related]
29. Effects of azaprophen, scopolamine and trihexyphenidyl on schedule-controlled behavior, before and after chronic physostigmine. Genovese RF Eur J Pharmacol; 1990 Feb; 176(3):271-9. PubMed ID: 2328755 [TBL] [Abstract][Full Text] [Related]
30. Cholinergic modulation of the hippocampus during encoding and retrieval of tone/shock-induced fear conditioning. Rogers JL; Kesner RP Learn Mem; 2004; 11(1):102-7. PubMed ID: 14747523 [TBL] [Abstract][Full Text] [Related]
31. Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol. Schiller D; Zuckerman L; Weiner I J Psychiatr Res; 2006 Mar; 40(2):167-77. PubMed ID: 15882871 [TBL] [Abstract][Full Text] [Related]
32. Sexually diergic hypothalamic-pituitary-adrenal axis responses to selective and non-selective muscarinic antagonists prior to cholinergic stimulation by physostigmine in rats. Smail MA; Soles JL; Karwoski TE; Rubin RT; Rhodes ME Brain Res Bull; 2018 Mar; 137():23-34. PubMed ID: 29122691 [TBL] [Abstract][Full Text] [Related]
33. Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine. Preston GC; Ward C; Lines CR; Poppleton P; Haigh JR; Traub M Psychopharmacology (Berl); 1989; 98(4):487-94. PubMed ID: 2570433 [TBL] [Abstract][Full Text] [Related]
34. Effects of physostigmine on the startle in guinea pigs: two mechanisms involved. Philippens IH; Olivier B; Melchers BP Pharmacol Biochem Behav; 1997 Dec; 58(4):909-13. PubMed ID: 9408195 [TBL] [Abstract][Full Text] [Related]
35. Effects of repeated treatment with methamphetamine plus scopolamine and methamphetamine on behavioral sensitization and conditioning. Yui K; Miura T; Sugiyama K; Ono M; Nagase M Behav Brain Res; 1996 Oct; 80(1-2):169-75. PubMed ID: 8905140 [TBL] [Abstract][Full Text] [Related]
36. A pharmacological analysis of processes underlying differential responding: a review and further experiments with scopolamine, amphetamine, lysergic acid diethylamide (LSD-25), chlordiazepoxide, physostigmine, and chlorpromazine. Frontali M; Amorico L; De Acetis L; Bignami G Behav Biol; 1976 Sep; 18(1):1-74. PubMed ID: 791242 [No Abstract] [Full Text] [Related]
38. Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis? Arad M; Weiner I Neuropsychopharmacology; 2010 Jun; 35(7):1570-82. PubMed ID: 20237462 [TBL] [Abstract][Full Text] [Related]
39. A computer-automated touchscreen paired-associates learning (PAL) task for mice: impairments following administration of scopolamine or dicyclomine and improvements following donepezil. Bartko SJ; Vendrell I; Saksida LM; Bussey TJ Psychopharmacology (Berl); 2011 Mar; 214(2):537-48. PubMed ID: 21086119 [TBL] [Abstract][Full Text] [Related]
40. Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex. Jones CK; Shannon HE J Pharmacol Exp Ther; 2000 Sep; 294(3):1017-23. PubMed ID: 10945854 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]